Navigation Links
Regence Teams With U.S. Bank to Offer New Health Savings Account Solution
Date:10/29/2008

PORTLAND, Ore., Oct. 29 /PRNewswire/ -- Members who choose Regence's Health Savings Account (HSA) will soon benefit from a new banking option, now that the company has added U.S. Bank as a banking partner. Regence selected U.S. Bank for its comprehensive approach to health care banking and its strong consumer track record.

"We are proud to partner with an established financial institution and brand like U.S. Bank to offer our members the superior level of quality and financial services they have come to expect from Regence," said Cary Badger, vice president of Market Development for Regence. "U.S. Bank's experience, strong brand recognition and flexibility in online servicing capabilities embody our shared philosophy of supporting members in their health care decisions."

U.S. Bank will serve as the debit card issuer and funds custodian for the Regence HSA. Their responsibilities will include providing account banking and all debit card services, card administration, customer service, web site portal maintenance and issuance of bank and tax statements. Their web site also provides easy access to the member accounts, and employer and agent tools.

"We are very pleased and honored that Regence chose us as their HSA partner," said Ralph Bernstein, U.S. Bank's senior vice president of Healthcare Payment Solutions. "Together, our two companies share a long-standing commitment to outstanding customer support and service. We look forward to working with Regence to demonstrate our commitment to their members, every day."

Each of Regence's partner banks hosts a co-branded web site that enables employers to monitor their HSA program and provides members 24-hour access to their account deposits and balance transaction history. With Regence's new HSA 2.0, scheduled for launch later this year, members will receive a Regence co-branded debit card to pay for any qualified medical expense.

About U.S. Bank

U.S. Bancorp (NYSE: USB), with $247 billion in assets, is the parent company of U.S. Bank, the 6th largest commercial bank in the United States as of June 30, 2008. The company operates 2,542 banking offices and 4,895 ATMs, and provides a comprehensive line of banking, brokerage, insurance, investment, mortgage, trust and payment services products to consumers, businesses and institutions. Visit U.S. Bancorp on the web at http://www.usbank.com.

About Regence

Regence is the largest health insurer in the Northwest / Intermountain Region, serving three million members as Regence BlueCross BlueShield of Oregon, Regence BlueShield (selected counties in Washington), Regence BlueCross BlueShield of Utah and Regence BlueShield of Idaho. Each plan is a not-for-profit independent licensee of the Blue Cross and Blue Shield Association. Regence is committed to improving the health of our members and our communities, and to transforming our health care system. For more information, please visit http://www.regence.com.


'/>"/>
SOURCE Regence
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Regence Offers InterM to Fill Gap for the Uninsured
2. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
3. Regence Expands MedAdvantage Market, Hits the Road to Educate Seniors
4. Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship
5. Regence Introduces Two New Plans Designed Especially for Small to Mid-Size Companies
6. American Heart Association Honors Regence BlueCross BlueShield of Utah as the States First Start! Fit-Friendly Company
7. American Heart Association Award Recognizes Regence as a Start! Fit-Friendly Company
8. Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need
9. myRegence.com Wins Three Gold Awards from eHealthcare Strategy & Trends
10. Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options
11. Regence Automates Provider Contracting with Kryptiqs Choreo Contract Manager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of Buzzies ... stress and anxiety. , “Buzzies change the way we interact with stress and ... , Since its launch date in December 2016, The TouchPoint Solution has sold more ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... 23, 2017 , ... It’s that time of year again! Time to think ... summer internships , which can be frustrating when they don’t even know how to ... a boutique public relations firm outside of Philadelphia, have offered these three tips to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... skincare products, was awarded as winners of American Dreams & Good Housekeeping Seal ... hosted jointly by HSN and Good Housekeeping. , Steven Wang, MD ., ...
(Date:3/23/2017)... , ... March 23, 2017 , ... News Advisory/Interview Opportunity ... has helped score a major victory in Europe for public health and the environment ... , Based on rigorous scientific research and the overwhelming support of European citizens, the ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: